Enabling steerability at the microscale: the significance of nitinol
Steerability is a defining requirement in next-generation medical tools as minimally invasive procedures ramp up and expand applications. Gastrointestinal (GI), …
Post
-
-
Philips introduces SmartIQ AI software for coronary imaging advancement
Philips has introduced SmartIQ, a new artificial intelligence (AI)-based software algorithm for improving image quality and optimising radiation dosing during …
-
Hospital at home: the new model of modern care
Professor Rachid El Fatimy, dean of the Faculty of Medical Sciences and hospital general director at University Mohammed VI Polytechnic …
-
EmStop begins CAPTURE-2 trial of embolic protection system
EmStop has commenced the CAPTURE-2 investigational device exemption (IDE) clinical trial, assessing its embolic protection system during transcatheter aortic valve …
-
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific has announced a $1.5bn investment to acquire approximately a 34% equity stake in MiRus, a company developing the …
-
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific has announced a $1.5bn investment to acquire approximately a 34% equity stake in MiRus, a company developing the …
-
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US …
-
Podcast: MHRA CEO Lawrence Tallon on the future of medical device regulation in the UK
Since taking over from Dame June Raine as CEO of the Medicines and Healthcare products Regulatory Agency (MHRA) in April …
-
Embecta acquires Owen Mumford for $172.6m
Embecta has completed its acquisition of UK-based medical device manufacturer Owen Mumford Holdings in a deal valued at up to …
-
Valar Labs hits US first with breakthrough designation for AI bladder cancer test
Valar Labs’ Vesta Bladder Risk Stratify Dx has secured breakthrough device designation from the US Food and Drug Administration (FDA), …
-
PainTEQ announces US launch of SI joint implant
PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior sacroiliac (SI) joint fusion, in the US. The …
-
FDA clears Glooko’s cloud-based insulin dosing platform
Glooko has secured US Food and Drug Administration (FDA) clearance for EndoTool IV Cloud, priming the cloud-based insulin dosing platform …
-
Butterfly Medical raises $21m in funds for BPH device development
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device …
-
Biopharma industry endorses Pazdur for FDA commissioner role
With the leadership role of the US Food and Drug Administration (FDA) vacant following Marty Makary’s resignation earlier this week, …
-
BlueWind Medical raises $47.8m to advance commercialisation efforts for UUI treatment
BlueWind Medical has raised $47.8m to expand commercialisation of its implantable tibial neuromodulation (iTNM) system for urge urinary incontinence (UUI) treatment. Originating …
